Regeneron Pharmaceuticals
REGN
#302
Rank
โ‚น5.258 T
Marketcap
โ‚น48,099
Share price
2.53%
Change (1 day)
-35.60%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): โ‚น3,085

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น3,191. In 2022 the company made an earnings per share (EPS) of โ‚น3,461 a decrease over its 2021 EPS that were of โ‚น6,530.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น3,085-10.87%
2022โ‚น3,461-47%
2021โ‚น6,530133.36%
2020โ‚น2,79869.13%
2019โ‚น1,654-14.44%
2018โ‚น1,934100.71%
2017โ‚น963.4131.78%
2016โ‚น731.1038.96%
2015โ‚น526.1272.55%
2014โ‚น304.91-17.55%
2013โ‚น369.82-44.98%
2012โ‚น672.17-422.54%
2011-โ‚น208.4092.13%
2010-โ‚น108.4749.41%
2009-โ‚น72.60-15.84%
2008-โ‚น86.26-36.88%
2007-โ‚น136.65-9.6%
2006-โ‚น151.174.12%
2005-โ‚น145.20-323.68%
2004โ‚น64.91-135.51%
2003-โ‚น182.78-24.38%
2002-โ‚น241.7156.35%
2001-โ‚น154.59187.3%
2000-โ‚น53.81-16%
1999-โ‚น64.06177.78%
1998-โ‚น23.06-35.71%
1997-โ‚น35.87-68.42%
1996-โ‚น113.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,209-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น351.03-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,577-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,203-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น319.43-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น271.62-91.49%๐Ÿ‡ซ๐Ÿ‡ท France